News & Updates
Filter by Specialty:
Bezlotoxumab prevents CDI recurrence in immunocompromised patients
Treatment with bezlotoxumab results in a significant decrease in recurrent Clostridioides difficile infection (CDI) in a cohort of immunocompromised patients and transplant recipients, reports a study.
Bezlotoxumab prevents CDI recurrence in immunocompromised patients
16 Jul 2023
Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab
Time to recovery from COVID-19 pneumonia does not appear to differ following treatment with abatacept, cenicriviroc, or infliximab among hospitalized patients, according to a study.
Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab
15 Jul 2023
Danuglipron helps with glucose control, weight loss in T2D
The glucagon-like peptide 1 receptor (GLP-1R) agonist danuglipron appears to be beneficial in the treatment of patients with type 2 diabetes (T2D), yielding reductions in glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), and body weight, without fasting restrictions, as shown in the results of a phase IIb study.
Danuglipron helps with glucose control, weight loss in T2D
15 Jul 2023
Long-acting ART induces viral suppression in people with HIV
People with HIV (PWH) who are treated with long-acting (LA) antiretroviral therapy (ART) achieve virologic suppression, as do those with viraemia and challenges to adherence, reports a study.
Long-acting ART induces viral suppression in people with HIV
15 Jul 2023
Anxiety, depression jeopardize health of axSpA patients
Patients with axial spondyloarthritis (axSpA) may experience a decline in their overall health and functioning due to the presence of comorbid anxiety and depression, as reported in a study from Singapore.